Talos Energy Inc. (TALO) - Q2 2026 10-Q Summary
Business Context and Reporting Period
This Quarterly Report on Form 10-Q covers the period ended June 30, 2026. Talos Energy Inc. is an independent energy company focused on oil and gas exploration and production in the U.S. Gulf of America and offshore Mexico. The company operates a single reportable segment: Upstream.
Key Financial Metrics
| Metric | Q2 2026 (3 Months) | YTD 2026 (6 Months) | YTD 2025 (6 Months) |
|---|---|---|---|
| Total Revenues | $664.8 million | $1,137.1 million | $937.8 million |
| Net Income (Loss) | $149.9 million | ($106.1 million) | ($195.8 million) |
| Net Income (Loss) Attributable to Talos | $149.7 million | ($106.5 million) | ($195.8 million) |
| Diluted EPS | $0.88 | ($0.64) | ($1.10) |
| Operating Cash Flow | N/A | $474.6 million | $619.9 million |
| Capital Expenditures | N/A | $254.0 million | $276.1 million |
| Long-Term Debt | $1,228.8 million | $1,228.8 million | $1,226.2 million |
| Cash and Equivalents | $577.6 million | $577.6 million | $362.8 million |
| Adjusted EBITDA | $402.4 million | $695.8 million | $657.3 million |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased by $240.1 million (57%) in Q2 2026 compared to Q2 2025, driven primarily by a significant increase in realized oil prices ($99.47/Bbl vs. $64.08/Bbl) and higher oil production volumes.
- Profitability Turnaround: The company reported a net income of $149.9 million in Q2 2026, a stark contrast to the $185.9 million net loss in Q2 2025. This improvement is largely due to higher commodity prices and the absence of a large impairment charge in Q2 2026 (compared to a $223.9 million impairment in Q2 2025).
- Impairment Charges: For the six months ended June 30, 2026, the company recorded a $145.0 million impairment of oil and natural gas properties due to the full cost ceiling test. This is a reduction from the $223.9 million impairment recorded in the same period in 2025.
- Derivative Impact: Price risk management activities resulted in a $30.5 million gain in Q2 2026, compared to an $86.9 million gain in Q2 2025. For the six-month period, derivatives resulted in a $143.0 million expense, compared to a $71.0 million gain in the prior year.
- Production Volumes: Total production volumes decreased slightly year-over-year for the six-month period (91.3 MBoepd vs. 97.1 MBoepd), primarily due to declines at the Brutus and Galapagos fields, partially offset by incremental production at the Sunspear Field.
Guidance, Outlook, and Risks
- Pending Acquisitions: On June 30, 2026, Talos entered into an agreement to acquire the Coulomb and Na Kika assets from Shell for approximately $850 million. Closing is expected by the end of 2026. The company also announced a farm-in transaction in Offshore Mexico and an acquisition in Honduras.
- Debt Refinancing: Subsequent to the reporting period (July 13, 2026), the company issued $800 million of 8.000% Senior Secured Notes due 2034 and used the proceeds to redeem all $625 million of its 9.000% Notes due 2029.
- Capital Program: Management expects to fund the remaining 2026 capital spending program of $500 million to $550 million using operating cash flows and available credit facility capacity.
- Risks: Key risks include the failure to consummate pending transactions (Coulomb/Na Kika), commodity price volatility exacerbated by geopolitical tensions (specifically the war in Iran), and regulatory uncertainties regarding financial assurance requirements (BOEM rules) and the National Marine Fisheries Service Biological Opinion.
Investor Verification Checklist
- Acquisition Closing: Verify the status and closing conditions of the $850 million Coulomb and Na Kika acquisition, including regulatory approvals and funding sources.
- Debt Structure: Confirm the terms and impact of the new $800 million 8.000% Notes issued in July 2026 and the redemption of the 9.000% Notes.
- Impairment Sensitivity: Review the sensitivity of the full cost ceiling test to future commodity price fluctuations, given the $145 million impairment recorded YTD.
- Derivative Exposure: Analyze the remaining derivative positions (swaps and collars) through June 2027 and their potential impact on future cash flows if prices deviate from hedged levels.
- Regulatory Compliance: Monitor developments regarding BOEM financial assurance rules and the NMFS Biological Opinion, which could impact capital requirements and operational timelines.